中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月12日星期六
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2020, Vol. 27 Issue (29): 108-110    
  妇幼医学 本期目录 | 过刊浏览 | 高级检索 |
子宫下段钳夹联合药物治疗产后出血疗效观察
董春燕;刘海梅;张继红;廖莉君
江西省新余市妇幼保健院产二科,江西新余 338025
Observation on therapeutic effect of lower uterine segment clamp combined with drug therapy in treatment of postpartum hemorrhage
DONG Chun-yan LIU Hai-mei ZHANG Ji-hong LIAO Li-jun
The Second Department of Obstetrics, Xinyu Maternal and Child Health Hospital, Jiangxi Province, Xinyu 338025,China
全文: PDF (0 KB)   HTML (34 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨子宫下段钳夹联合药物治疗产后出血的效果。方法 选取2018年1月~2019年12月我院收治的80 例产后出血产妇作为研究对象,按照随机数字表法分为对照组(n=40)与观察组(n=40)。对照组采用单纯药物治疗,观察组采用子宫下段钳夹术联合药物治疗。比较两组的产后1、2、24 h 出血量及效果、止血显效时间、住院时间、血红蛋白水平、输血情况。结果 观察组的产后1、2、24 h 出血量少于对照组,差异均有统计学意义(P<0.05);观察组的治疗总有效率高于对照组,差异有统计学意义(P<0.05);观察组的止血显效时间、住院时间短于对照组,差异均有统计学意义(P<0.05)。观察组治疗后的血红蛋白水平高于对照组,差异有统计学意义(P<0.05),对照组治疗后的血红蛋白水平低于治疗前,差异有统计学意义(P<0.05)。观察组治疗前后的血红蛋白水平比较,差异无统计学意义(P>0.05)。观察组无需输血,对照组输血4 例,观察组的输血发生率低于对照组,差异有统计学意义(P>0.05)。结论 子宫下段钳夹联合药物治疗产后出血效果较好,可以缩短产妇的止血显效时间、住院时间,降低产后出血情况,对血红蛋白水平影响较小,降低输血量,应用价值较高。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 子宫下段钳夹药物治疗产后出血疗效    
AbstractObjective To explore the therapeutic effect of lower uterine segment clamp combined with drug therapy in the treatment of postpartum hemorrhage. Methods A total of 80 patients with postpartum hemorrhage admitted to our hospital from January 2018 to December 2019 were selected as research subjects and divided into the control group (n=40) and the observation group (n=40) by the random number table method. The control group was treated with drug therapy alone, while the observation group was treated with lower uterine segment clamp combined with drug therapy.The blood loss at 1, 2 and 24 h after delivery, the therapeutic effect, the hemostasis effect time, stay-in-hospital time,hemoglobin levels and blood transfusion status were compared between the two groups. Results The blood loss of the observation group at 1, 2 and 24 h after delivery was lower than that of the control group, and the difference was statistically significant (P<0.05). The total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant (P<0.05). The hemostasis effect time and the stay-in-hospital time of the observation group were shorter than those of the control group, and the differences were statistically significant (P<0.05). After treatment, the hemoglobin level of the observation group was higher than that of the control group, and the difference was statistically significant (P<0.05); while the hemoglobin level of the control group after treatment was lower than that before treatment, and the difference was statistically significant (P<0.05). There was no significant difference in the hemoglobin level of the observation group between before and after treatment (P<0.05). No blood transfusion was required in the observation group, while 4 cases occurred in the control group. The incidence of blood transfusion in the observation group was lower than that in the control group, with statistical difference (P<0.05). Conclusion Lower uterine segment clamp combined with drug therapy is effective in the treatment of postpartum hemorrhage, which can shorten the hemostasis time and hospital stay time. It can also reduce postpartum hemorrhage, the influence on hemoglobin level, and the amount of blood transfusion. Therefore, it has high application value.
Key wordsLower uterine segment clamp    Drug therapy    Postpartum hemorrhage    Therapeutic effect
收稿日期: 2020-03-16     
引用本文:   
董春燕;刘海梅;张继红;廖莉君. 子宫下段钳夹联合药物治疗产后出血疗效观察[J]. 中国当代医药, 2020, 27(29): 108-110.
DONG Chun-yan LIU Hai-mei▲ ZHANG Ji-hong LIAO Li-jun. Observation on therapeutic effect of lower uterine segment clamp combined with drug therapy in treatment of postpartum hemorrhage. 中国当代医药, 2020, 27(29): 108-110.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2020/V27/I29/108
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载